Skin drug delivery can be subdivided into topical and transdermal. In a topical administration, the drug is intended to act at skin level, this is indicated for the treatment of skin diseases such as follicle-related disorders (for example, acne and alopecias). The aim of transdermal administration is getting a systemic release, and in this case the skin represents a barrier and not a target. Transdermal administration can take advantage of chemical and physical strategies that can improve skin permeability and can allow to drug penetration.In this study the development of the skin penetration profile have carried out by in vitro technique for a microencapsulated system of Ibuprofen and was determined using pig skin. The release experiments are performed using absorption percutaneous test with Franz cells apparatus in order to know the evolution of the amount of the principle present in each of the different skin compartments (stratum corneum, epidermis and dermis) as well as in the receptor fluid, as a function of time by HPLC analysis. It has achieved a general kinetic model by a microencapsulated system as mass transport system through the skin. This modelization could serve to predict penetration in human skin of encapsulated substances from biofunctional textiles and the estimation of the dosification profile of the active principle.